NeuroSense Therapeutics Ltd. (NRSN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 | Q1'20 |
|---|
| Total Current Assets | 1.56M | 1.56M | 4.4M | 785K | 1.62M | 1.19M | 2.92M | 5.11M | 7.56M | 5.02M | 7.38M | 8.89M | 11.1M | 14.03M | 11.41M | 1.01M | 699K | 766K | 766K | 895K |
| Cash & Short-Term Investments | 666K | 666K | 3.38M | 344K | 1.24M | 735K | 2.64M | 4.76M | 7.09M | 4.41M | 7.09M | 8.44M | 10.37M | 13.74M | 11.06M | 994K | 699K | 699K | 699K | 895K |
| Cash Only | 666K | 666K | 3.38M | 344K | 1.21M | 735K | 2.64M | 4.76M | 7.09M | 1.36M | 3.54M | 4.41M | 4.35M | 8.73M | 11.06M | 994K | -699K | 699K | 699K | -895K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 35K | 0 | 0 | 0 | 0 | 3.05M | 3.55M | 4.03M | 6.03M | 5M | 0 | 0 | 1.4M | 0 | 0 | 1.79M |
| Accounts Receivable | 847K | 0 | 164K | 406K | 376K | 421K | 166K | 309K | 434K | 567K | 131K | 425K | 707K | 225K | 178K | 16K | 0 | 30K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.65K | 37.53K | 38.39K | 0 | 0 | 0 | 0 | -178K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 43K | 890K | 35K | 35K | 35K | 36K | 40K | 346 | 472 | 606 | 36K | 23K | 23K | 64K | 171K | 16K | -699K | 37K | 67K | 0 |
| Total Non-Current Assets | 128K | 128K | 173K | 199K | 222K | 254K | 269K | 281K | 307K | 317K | 329K | 338K | 349K | 329K | 19K | 52K | -699K | 13K | 13K | -895K |
| Property, Plant & Equipment | 105K | 105K | 150K | 176K | 200K | 231K | 247K | 260K | 284K | 294K | 306K | 304K | 314K | 329K | 19K | 15K | 0 | 13K | 13K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 23K | 22K | 0 | 0 | 21K | 23K | 23K | 0 | 34K | 35K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 23K | 23K | 23K | 0 | 0 | 23K | 22K | 0 | 0 | 0 | 23K | 0 | 0 | 0 | 0 | 37K | -699K | 0 | 0 | -895K |
| Total Assets | 1.68M | 1.68M | 4.58M | 984K | 1.84M | 1.45M | 3.19M | 5.39M | 7.87M | 5.33M | 7.71M | 9.23M | 11.45M | 14.36M | 11.43M | 1.06M | 0 | 779K | 779K | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -8.53% | 16.46% | 43.64% | -81.73% | -76.6% | -72.9% | -58.69% | -41.65% | -31.3% | -62.84% | -32.55% | - | 978.44% | - | 1367.39% | - | - | - | - | - |
| Total Current Liabilities | 2.2M | 2.2M | 1.99M | 3.78M | 3.51M | 4.54M | 3.46M | 2.81M | 3M | 1.79M | 1.73M | 811K | 736K | 1.23M | 597K | 125K | 0 | 120K | 120K | 0 |
| Accounts Payable | 1.09M | 1.09M | 1.16M | 1.39M | 1.48M | 2.38M | 1.46M | 913K | 1.09M | 419K | 498K | 206K | 120K | 180K | 39K | 12K | 0 | 55K | 55K | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 1.11M | 0 | 0 | 2.02M | 0 | 0 | 1.9M | 1.92M | 1.37M | 370K | 605K | 616K | 1.05M | 0 | 0 | 0 | 0 | 65K | 0 |
| Current Ratio | 0.71x | 0.71x | 2.21x | 0.21x | 0.46x | 0.26x | 0.84x | 1.82x | 2.52x | 2.80x | 4.28x | 10.96x | 15.09x | 11.42x | 19.12x | 8.08x | - | 6.38x | 6.38x | - |
| Quick Ratio | 0.71x | 0.71x | 2.21x | 0.21x | 0.46x | 0.26x | 0.84x | 1.80x | 2.50x | 2.78x | 4.28x | 10.96x | 15.09x | 11.42x | 19.41x | 8.08x | - | 6.38x | 6.38x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 19K | 36K | 3.9M | 1.49M | 2.77M | 6.41M | 653K | 365K | 573K | 881K | 1.02M | 1.83M | 0 | -659K | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 19K | 36K | 55K | 73K | 84K | 104K | 126K | 147K | 173K | 190K | 207K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 3.85M | 1.41M | 2.69M | 6.3M | 527K | 218K | 400K | 691K | 816K | 1.83M | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.2M | 2.2M | 1.99M | 3.8M | 3.54M | 8.44M | 4.94M | 5.58M | 9.41M | 2.45M | 2.09M | 1.38M | 1.62M | 2.25M | 2.42M | 125K | -659K | 120K | 120K | 0 |
| Total Debt | 0 | 0 | 73K | 19K | 36K | 55K | 142K | 84K | 104K | 126K | 211K | 173K | 190K | 207K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -666K | -666K | -3.31M | -325K | -1.17M | -680K | -2.5M | -4.67M | -6.99M | -1.23M | -3.33M | -4.24M | -4.16M | -8.53M | -11.06M | -994K | 699K | -699K | -699K | 895K |
| Debt / Equity | - | - | 0.03x | - | - | - | - | - | - | 0.04x | 0.04x | 0.02x | 0.02x | 0.02x | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.03x | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -1.57x | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -276.00x | -276.00x | -59.03x | -51.39x | - | -1.24x | -3.10x | 248.83x | -20.03x | -8.43x | - | -298.40x | -98.46x | -117.04x | -1.43x | - | -162.38x | - | - | - |
| Total Equity | -519K | -519K | 2.58M | -2.82M | -1.7M | -6.99M | -1.76M | -196K | -1.54M | 2.89M | 5.62M | 7.85M | 9.84M | 12.11M | 9.01M | 937K | 659K | 659K | 659K | 918K |
| Equity Growth % | 69.52% | 92.58% | 246.84% | -1337.76% | -10.23% | -342.06% | -131.3% | -102.5% | -115.71% | -76.14% | -37.61% | - | 949.73% | 1737.03% | 1266.62% | - | -28.21% | - | - | - |
| Book Value per Share | -0.02 | -0.02 | 0.12 | -0.14 | -0.09 | -0.45 | -0.11 | -0.01 | -0.11 | 0.25 | 0.48 | 0.68 | 0.85 | 1.07 | 0.82 | 0.09 | 0.12 | 0.12 | 0.12 | 0.17 |
| Total Shareholders' Equity | -519K | -519K | 2.58M | -2.82M | -1.7M | -6.99M | -1.76M | -196K | -1.54M | 2.89M | 5.62M | 7.85M | 9.84M | 12.11M | 9.01M | 937K | 659K | 659K | 659K | 918K |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -41.37M | -41.37M | -36.66M | -34.53M | -32.38M | -31.52M | -26.12M | -29.12M | -29.9M | -24.68M | -20.79M | -17.64M | -14.64M | -11.16M | -8.45M | -7.46M | 0 | -4.41M | -4.41M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 659K | 0 | 0 | 918K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |